Differential diagnostics of lung injury in patients with systemic lupus erythematosus and antiphospholipidic syndrome: clinical observation


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. In systemic lupus erythematosus (SLE), lung injury is not uncommon and requires therapy with cytostatics and glucocorticosteroids. With high clinical and immunological activity of SLE, an immunodeficiency state occurs, and the risk of infectious diseases, incl. tuberculosis, is increased. Description of the clinical case. A clinical case of a female patient with an interstitial lung injury is presented; differential diagnostics between tuberculous lesion and lung injury in SLE was performed. The importance of determination of the leading disease in connection with fundamentally different approaches to therapy for lupus pneumonitis and pulmonary tuberculosis is discussed. Conclusion. Lung injury in SLE in a patient with tuberculosis can cause diagnostic difficulties. Given the difference in tactics of treatment of SLE patients depending on the presence of comorbidities, immunosuppressive therapy in controversial situations should be prescribed with care.

Texto integral

Acesso é fechado

Sobre autores

E. Belolipetskaya

North-Western State Medical University n.a. I.I. Mechnikov

Email: lisa_osutina@list.ru
Postgraduate Student at the Department of Therapy and Rheumatology

I. Belyaeva

North-Western State Medical University n.a. I.I. Mechnikov

V. Mazurov

North-Western State Medical University n.a. I.I. Mechnikov

O. Inamova

Clinical Rheumatological Hospital № 25, St. Petersburg

M. Petrova

Clinical Rheumatological Hospital № 25, St. Petersburg

E. Mozharovskaya

Clinical Rheumatological Hospital № 25, St. Petersburg

Bibliografia

  1. Клюквина Н.Г., Асеева Е.А., Никонорова Н.О. Поражение легких при системной красной волчанке: хорошо известные факты и нерешенные вопросы. Научно-практическая ревматология. 2016;54(5):578-89.
  2. Cheema G.S., Quismorio F.P. Interstitial lung disease in systemic lupus erythematosus. Curr. Opin. Pulm. Med. 2000;6(5):424-29.
  3. Bouza E., Moya J.G., Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect. Dis. Clin. North. Am. 2001;15(2):335-61.
  4. Jick S.S., Lieberman E.S., Rahman M.U., Choi H.K. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthr. Rheum. 2006;55(1):19-26.
  5. Karkhanis V.S., Joshi J.M. Pleural effusion: diagnosis, treatment, and management. Open Access Emergency Med. 2012;4:31-52.
  6. Мишин В.Ю., Завражнов С.П., Митронин А.В. и др. Фтизиопульмонология. Учебник. М., 2015. 504 с.
  7. Ryan H., Yoo J., Darsini P. Corticosteroids for tuberculous pleurisy. The Cochrane Database of Systematic Reviews. 2017;3.
  8. Liu R., Zhang L., Gao S., et al. Gastrointestinal symptom due to lupus peritonitis: a rare form of onset of SLE. Int. J. Clin. Exp. Med. 2014;7(12):5917-20.
  9. Российские клинические рекомендации. Ревматология / Под ред. Е.Л. Насонова. М., 2017. 464 с.
  10. Marzano A.V., Tavecchio S., Menicanti C., Crosti C. Drug-induced lupus erythematosus. G. Ital. Dermatol.Venereol. 2014;149(3):301-9.
  11. Лапин С.В. и др. Методическое руководство по лабораторной диагностике аутоиммунных заболеваний / Под ред. В.Л. Эмануэля. 3-е изд., испр. и доп. СПб., 2017. 36 c.
  12. Лейнеман Я.А., Мазуров В.И., Файзенберг РМ. и др. Роль функциональной МСКТ и постпроцессинговой обработки в диагностике ранних поражений бронхолегочной системы у пациентов с системной красной волчанкой. Материалы Невского радиологического форума. СПб., 2015. С. 726-28.
  13. Руководство по аутоиммунным заболеваниям для врачей общей практики / Под ред. И. Шенфельда, П.Л. Мерони, Л.П. Чурилова, пер. c англ. Л.П. Чурилова. СПб., 2017. 416 с.
  14. Meroni P.L. Antiphospholipid antibody syndrome: from bench to bedside, rare diseases of the immune system. - Switzerland: Springer international publishing, 2015. 266 p.
  15. Taraborelli M., Lazzaroni M.G., Martinazzi N., et al. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus. Reumatismo. 2016;68(3): 137-43.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies